Companies /Healthcare

Apogee Therapeutics Inc

NASDAQ: APGE Biotechnology
$134.96
â–² $0.01 (+0.01%) today
Markets open · 2:12pm ET
Today · % change

Fundamentals

Market Cap
$10.2B
EPS (TTM)
$-4.35
52-Week Range
$35 – $135
Street Target
$134.85

About Apogee Therapeutics

Apogee Therapeutics Inc is a biotechnology firm based in Waltham, Massachusetts, focusing on creating innovative treatments for atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other related conditions. The company is known for its development of groundbreaking monoclonal antibodies, including APG777 for AD and APG808 for COPD, aiming to improve patients' lives through advanced biologics. Founded in 2022, Apogee Therapeutics is at the forefront of addressing unmet medical needs in inflammatory and immunology indications.

APGE Coverage